These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24473840)

  • 1. [Chronic myeloproliferative neoplasms].
    Griesshammer M; Döhner K
    Dtsch Med Wochenschr; 2014 Feb; 139(6):243-6. PubMed ID: 24473840
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloproliferative neoplasms.
    Kim J; Haddad RY; Atallah E
    Dis Mon; 2012 Apr; 58(4):177-94. PubMed ID: 22449367
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic myeloproliferative syndromes].
    de Ozalla CB; García Suárez J
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in understanding and management of myeloproliferative neoplasms.
    Vannucchi AM; Guglielmelli P; Tefferi A
    CA Cancer J Clin; 2009; 59(3):171-91. PubMed ID: 19369682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.
    Cherington C; Slack JL; Leis J; Adams RH; Reeder CB; Mikhael JR; Camoriano J; Noel P; Fauble V; Betcher J; Higgins MS; Gillette-Kent G; Tremblay LD; Peterson ME; Olsen JJ; Tibes R; Mesa RA
    Leuk Res; 2012 Sep; 36(9):1147-51. PubMed ID: 22578777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current world literature.
    Curr Opin Hematol; 2011 Mar; 18(2):124-31. PubMed ID: 21307671
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management of chronic myeloproliferative disorders].
    Ikkala E; Hormila P
    Duodecim; 1989; 105(11):1007-15. PubMed ID: 2473873
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab and autologous stem cell transplantation for malignant lymphoma after liver transplantation.
    Sánchez-González B; Fernández-Abellán P; Garcia Garay MC; Villarrubia B; Palmero MF; Rivas C
    Bone Marrow Transplant; 2004 May; 33(10):1071-2. PubMed ID: 15034545
    [No Abstract]   [Full Text] [Related]  

  • 9. Myeloproliferative neoplasms: new translational therapies.
    Mascarenhas J; Hoffman R
    Mt Sinai J Med; 2010; 77(6):667-83. PubMed ID: 21105128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview.
    Tefferi A
    Mayo Clin Proc; 1998 Dec; 73(12):1177-84. PubMed ID: 9868417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focus on myeloproliferative diseases and myelodysplastic syndromes.
    Van Etten RA; Shannon KM
    Cancer Cell; 2004 Dec; 6(6):547-52. PubMed ID: 15607959
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia.
    Tholouli E; Liakopoulou E; Greenfield HM; Shaw BE; Tauro S; Byrne JL; Dennis M; Burthem J; Lucas GS; Craddock C; Russell NH; Liu Yin JA
    Br J Haematol; 2008 Jun; 142(2):318-20. PubMed ID: 18492100
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic stem cell transplantation for chronic myeloproliferative disorders and myelodysplastic syndromes: the question is "when?".
    Maziarz RT; Mesa RA; Tefferi A
    Mayo Clin Proc; 2003 Aug; 78(8):941-3. PubMed ID: 12911040
    [No Abstract]   [Full Text] [Related]  

  • 14. Myelodysplastic and myeloproliferative disorders in children.
    Hasle H
    Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic malignant histiocytosis: 5 cases of a special form of lympho-reticular systemic disease].
    Schreml W; Galle J; Heimpel H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1100-2. PubMed ID: 611801
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel ETV6-PDGFRB fusion transcript missed by standard screening in a patient with an imatinib responsive chronic myeloproliferative disease.
    Curtis CE; Grand FH; Waghorn K; Sahoo TP; George J; Cross NC
    Leukemia; 2007 Aug; 21(8):1839-41. PubMed ID: 17508004
    [No Abstract]   [Full Text] [Related]  

  • 17. The myelodysplastic syndromes and myeloproliferative disorders.
    Williams JL
    Clin Lab Sci; 2004; 17(4):223-34. PubMed ID: 15559729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid disease.
    Tallman MS
    Curr Opin Hematol; 2009 Mar; 16(2):63. PubMed ID: 19468265
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS.
    Dirnhofer S; Went P; Tichelli A
    Pathobiology; 2007; 74(2):115-20. PubMed ID: 17587882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of plasma fibronectin levels].
    Cseh K; Kalabay L; Jakab L; Török J; Marticsek J; Benedek S; Pozsonyi T; Szklenárik G
    Orv Hetil; 1986 Mar; 127(10):577-8, 581-2. PubMed ID: 3703538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.